Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 115,38
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
EUR 134,39
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 304.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 152,17
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 304 pages. 9.06x6.14x0.91 inches. In Stock.
Librería: preigu, Osnabrück, Alemania
EUR 95,15
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neocarzinostatin | The Past, Present, and Future of Anticancer Drug | Hiroshi Maeda (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2013 | Springer Japan | EAN 9784431669166 | Verantwortliche Person für die EU: Springer Nature Customer Service Center GmbH, Tiergartenstr. 17, 69121 Heidelberg, productsafety[at]springernature[dot]com | Anbieter: preigu.
EUR 118,64
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 112,77
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - The 20th century has witnessed the great benefits of the development of antibi otics, which became a reality after World War IL More than 50 years ago I witnessed the miraculous therapeutic power of penicillin, when I was a student at the Tohoku University Medical School's Department of Bacteriology in Sendai, Japan. The late Dr. Kondo was a graduate student in the department at that time and developed the first crude penicillin preparation in Japan which was applied with dramatic results in two patients. Although there was patient-family consent at that time, ethics committees, randomization. mutagenesis tests, distribution studies, purity-criteria, and phar macokinetics were not yet in existence. Today, regulatory procedures have com plicated the whole drug-approval process. For example, any new antibiotics that have been proven effective in laboratory studies against gram-negative bacteria, as might exist in deadly plague bacteria, must still undergo a long and enormously costly regulatory process before they can be introduced to benefit society, and before government insurance can be applied.
Idioma: Inglés
Publicado por Springer, Springer Okt 2013, 2013
ISBN 10: 4431669167 ISBN 13: 9784431669166
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 106,99
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The 20th century has witnessed the great benefits of the development of antibi otics, which became a reality after World War IL More than 50 years ago I witnessed the miraculous therapeutic power of penicillin, when I was a student at the Tohoku University Medical School's Department of Bacteriology in Sendai, Japan. The late Dr. Kondo was a graduate student in the department at that time and developed the first crude penicillin preparation in Japan which was applied with dramatic results in two patients. Although there was patient-family consent at that time, ethics committees, randomization. mutagenesis tests, distribution studies, purity-criteria, and phar macokinetics were not yet in existence. Today, regulatory procedures have com plicated the whole drug-approval process. For example, any new antibiotics that have been proven effective in laboratory studies against gram-negative bacteria, as might exist in deadly plague bacteria, must still undergo a long and enormously costly regulatory process before they can be introduced to benefit society, and before government insurance can be applied. 304 pp. Englisch.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 136,20
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 304.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 138,52
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 304.